drugset / Trial / NCT02557672

PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding

NCT02557672 ↗

Phase 4 Completed 106 enrolled Mayo Clinic CSL Behring · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

This will be the first prospective randomized controlled clinical trial directly comparing Prothrombin Complex Concentrate (PCC) Compared to Fresh Frozen Plasma (FFP) for post cardiopulmonary bypass microvascular bleeding and factor-mediated coagulopathy. Is there a difference in bleeding and transfusion requirements in patients received PCC versus FFP?

Timeline

Start
2016-08
Primary completion
2021-06
Completion
2022-01

Outcome

Missed primary endpoint

registry analysis (superiority test); Fresh Frozen Plasma vs Prothrombin Complex Concentrate; p = 0.84 NCT02557672 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fresh Frozen Plasma (FFP) Protein / enzyme biologic 10 unknown —
Comparator Fresh Frozen Plasma (FFP) Protein / enzyme biologic 15 unknown —
Subject Prothrombin Complex Concentrate Protein / enzyme biologic 15 iu/kg —

Indications